4//SEC Filing
Nouri Alaleh 4
Accession 0001628280-24-020433
CIK 0001588978other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 9:40 PM ET
Size
23.6 KB
Accession
0001628280-24-020433
Insider Transaction Report
Form 4
Nouri Alaleh
EVP, CLO, CORP. SEC.
Transactions
- Exercise/Conversion
Common Stock
2024-05-03$4.56/sh+1,467$6,690→ 63,939 total - Exercise/Conversion
Common Stock
2024-05-03$5.18/sh+3,965$20,539→ 67,904 total - Exercise/Conversion
Common Stock
2024-05-03$7.27/sh+25,000$181,750→ 92,904 total - Sale
Common Stock
2024-05-03$60.84/sh−391$23,788→ 92,513 total - Sale
Common Stock
2024-05-03$61.28/sh−1,536$94,126→ 90,977 total - Sale
Common Stock
2024-05-03$62.79/sh−13,935$874,979→ 77,042 total - Sale
Common Stock
2024-05-03$63.38/sh−14,437$915,017→ 62,605 total - Sale
Common Stock
2024-05-03$64.04/sh−133$8,517→ 62,472 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-03−1,467→ 12,230 totalExercise: $4.56Exp: 2029-12-11→ Common Stock (1,467 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-03−3,965→ 16,160 totalExercise: $5.18Exp: 2030-08-08→ Common Stock (3,965 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-03−25,000→ 32,894 totalExercise: $7.27Exp: 2031-06-21→ Common Stock (25,000 underlying)
Footnotes (8)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.02 to $64.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F6]The Stock option was granted on December 12, 2019 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.
- [F7]The Stock option was granted on August 10, 2020 and vests 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date.
- [F8]The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of June 22, 2021 and the remainder vests on each monthly anniversary over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.
Documents
Issuer
PROCEPT BioRobotics Corp
CIK 0001588978
Entity typeother
Related Parties
1- filerCIK 0001599418
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 9:40 PM ET
- Size
- 23.6 KB